Cargando…

A Machine Learning Workflow of Multiplexed Immunofluorescence Images to Interrogate Activator and Tolerogenic Profiles of Conventional Type 1 Dendritic Cells Infiltrating Melanomas of Disease-Free and Metastatic Patients

Melanoma is the deadliest form of skin cancer. Due to its high mutation rates, melanoma is a convenient model to study antitumor immune responses. Dendritic cells (DCs) play a key role in activating cytotoxic CD8(+) T lymphocytes and directing them to kill tumor cells. Although there is evidence tha...

Descripción completa

Detalles Bibliográficos
Autores principales: De León Rodríguez, Saraí G., Hernández Herrera, Paúl, Aguilar Flores, Cristina, Pérez Koldenkova, Vadim, Guerrero, Adán, Mantilla, Alejandra, Fuentes-Pananá, Ezequiel M., Wood, Christopher, Bonifaz, Laura C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581597/
https://www.ncbi.nlm.nih.gov/pubmed/36276271
http://dx.doi.org/10.1155/2022/9775736
_version_ 1784812659181355008
author De León Rodríguez, Saraí G.
Hernández Herrera, Paúl
Aguilar Flores, Cristina
Pérez Koldenkova, Vadim
Guerrero, Adán
Mantilla, Alejandra
Fuentes-Pananá, Ezequiel M.
Wood, Christopher
Bonifaz, Laura C.
author_facet De León Rodríguez, Saraí G.
Hernández Herrera, Paúl
Aguilar Flores, Cristina
Pérez Koldenkova, Vadim
Guerrero, Adán
Mantilla, Alejandra
Fuentes-Pananá, Ezequiel M.
Wood, Christopher
Bonifaz, Laura C.
author_sort De León Rodríguez, Saraí G.
collection PubMed
description Melanoma is the deadliest form of skin cancer. Due to its high mutation rates, melanoma is a convenient model to study antitumor immune responses. Dendritic cells (DCs) play a key role in activating cytotoxic CD8(+) T lymphocytes and directing them to kill tumor cells. Although there is evidence that DCs infiltrate melanomas, information about the profile of these cells, their activity states, and potential antitumor function remains unclear, particularly for conventional DCs type 1 (cDC1). Approaches to profiling tumor-infiltrating DCs are hindered by their diversity and the high number of signals that can affect their state of activation. Multiplexed immunofluorescence (mIF) allows the simultaneous analysis of multiple markers, but image-based analysis is time-consuming and often inconsistent among analysts. In this work, we evaluated several machine learning (ML) algorithms and established a workflow of nine-parameter image analysis that allowed us to study cDC1s in a reproducible and accessible manner. Using this workflow, we compared melanoma samples between disease-free and metastatic patients at diagnosis. We observed that cDC1s are more abundant in the tumor infiltrate of the former. Furthermore, cDC1s in disease-free patients exhibit an expression profile more congruent with an activator function: CD40(high)PD-L1(low) CD86(+)IL-12(+). Although disease-free patients were also enriched with CD40(−)PD-L1(+) cDC1s, these cells were also more compatible with an activator phenotype. The opposite was true for metastatic patients at diagnosis who were enriched for cDC1s with a more tolerogenic phenotype (CD40(low)PD-L1(high)CD86(−)IL-12(−)IDO(+)). ML-based workflows like the one developed here can be used to analyze complex phenotypes of other immune cells and can be brought to laboratories with standard expertise and computer capacity.
format Online
Article
Text
id pubmed-9581597
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-95815972022-10-20 A Machine Learning Workflow of Multiplexed Immunofluorescence Images to Interrogate Activator and Tolerogenic Profiles of Conventional Type 1 Dendritic Cells Infiltrating Melanomas of Disease-Free and Metastatic Patients De León Rodríguez, Saraí G. Hernández Herrera, Paúl Aguilar Flores, Cristina Pérez Koldenkova, Vadim Guerrero, Adán Mantilla, Alejandra Fuentes-Pananá, Ezequiel M. Wood, Christopher Bonifaz, Laura C. J Oncol Research Article Melanoma is the deadliest form of skin cancer. Due to its high mutation rates, melanoma is a convenient model to study antitumor immune responses. Dendritic cells (DCs) play a key role in activating cytotoxic CD8(+) T lymphocytes and directing them to kill tumor cells. Although there is evidence that DCs infiltrate melanomas, information about the profile of these cells, their activity states, and potential antitumor function remains unclear, particularly for conventional DCs type 1 (cDC1). Approaches to profiling tumor-infiltrating DCs are hindered by their diversity and the high number of signals that can affect their state of activation. Multiplexed immunofluorescence (mIF) allows the simultaneous analysis of multiple markers, but image-based analysis is time-consuming and often inconsistent among analysts. In this work, we evaluated several machine learning (ML) algorithms and established a workflow of nine-parameter image analysis that allowed us to study cDC1s in a reproducible and accessible manner. Using this workflow, we compared melanoma samples between disease-free and metastatic patients at diagnosis. We observed that cDC1s are more abundant in the tumor infiltrate of the former. Furthermore, cDC1s in disease-free patients exhibit an expression profile more congruent with an activator function: CD40(high)PD-L1(low) CD86(+)IL-12(+). Although disease-free patients were also enriched with CD40(−)PD-L1(+) cDC1s, these cells were also more compatible with an activator phenotype. The opposite was true for metastatic patients at diagnosis who were enriched for cDC1s with a more tolerogenic phenotype (CD40(low)PD-L1(high)CD86(−)IL-12(−)IDO(+)). ML-based workflows like the one developed here can be used to analyze complex phenotypes of other immune cells and can be brought to laboratories with standard expertise and computer capacity. Hindawi 2022-10-12 /pmc/articles/PMC9581597/ /pubmed/36276271 http://dx.doi.org/10.1155/2022/9775736 Text en Copyright © 2022 Saraí G. De León Rodríguez et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
De León Rodríguez, Saraí G.
Hernández Herrera, Paúl
Aguilar Flores, Cristina
Pérez Koldenkova, Vadim
Guerrero, Adán
Mantilla, Alejandra
Fuentes-Pananá, Ezequiel M.
Wood, Christopher
Bonifaz, Laura C.
A Machine Learning Workflow of Multiplexed Immunofluorescence Images to Interrogate Activator and Tolerogenic Profiles of Conventional Type 1 Dendritic Cells Infiltrating Melanomas of Disease-Free and Metastatic Patients
title A Machine Learning Workflow of Multiplexed Immunofluorescence Images to Interrogate Activator and Tolerogenic Profiles of Conventional Type 1 Dendritic Cells Infiltrating Melanomas of Disease-Free and Metastatic Patients
title_full A Machine Learning Workflow of Multiplexed Immunofluorescence Images to Interrogate Activator and Tolerogenic Profiles of Conventional Type 1 Dendritic Cells Infiltrating Melanomas of Disease-Free and Metastatic Patients
title_fullStr A Machine Learning Workflow of Multiplexed Immunofluorescence Images to Interrogate Activator and Tolerogenic Profiles of Conventional Type 1 Dendritic Cells Infiltrating Melanomas of Disease-Free and Metastatic Patients
title_full_unstemmed A Machine Learning Workflow of Multiplexed Immunofluorescence Images to Interrogate Activator and Tolerogenic Profiles of Conventional Type 1 Dendritic Cells Infiltrating Melanomas of Disease-Free and Metastatic Patients
title_short A Machine Learning Workflow of Multiplexed Immunofluorescence Images to Interrogate Activator and Tolerogenic Profiles of Conventional Type 1 Dendritic Cells Infiltrating Melanomas of Disease-Free and Metastatic Patients
title_sort machine learning workflow of multiplexed immunofluorescence images to interrogate activator and tolerogenic profiles of conventional type 1 dendritic cells infiltrating melanomas of disease-free and metastatic patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581597/
https://www.ncbi.nlm.nih.gov/pubmed/36276271
http://dx.doi.org/10.1155/2022/9775736
work_keys_str_mv AT deleonrodriguezsaraig amachinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients
AT hernandezherrerapaul amachinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients
AT aguilarflorescristina amachinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients
AT perezkoldenkovavadim amachinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients
AT guerreroadan amachinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients
AT mantillaalejandra amachinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients
AT fuentespananaezequielm amachinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients
AT woodchristopher amachinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients
AT bonifazlaurac amachinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients
AT deleonrodriguezsaraig machinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients
AT hernandezherrerapaul machinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients
AT aguilarflorescristina machinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients
AT perezkoldenkovavadim machinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients
AT guerreroadan machinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients
AT mantillaalejandra machinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients
AT fuentespananaezequielm machinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients
AT woodchristopher machinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients
AT bonifazlaurac machinelearningworkflowofmultiplexedimmunofluorescenceimagestointerrogateactivatorandtolerogenicprofilesofconventionaltype1dendriticcellsinfiltratingmelanomasofdiseasefreeandmetastaticpatients